Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-2206 in Metastatic Colorectal Cancer
NCT01802320Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 2013
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MK-2206 in colorectal cancer (CRC), sponsored by National Cancer Institute. Started Mar 2013; status: completed.
02
Drugs
MK-2206
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01802320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01802320.